Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313220652> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4313220652 endingPage "479" @default.
- W4313220652 startingPage "479" @default.
- W4313220652 abstract "Introduction: Clinical pharmacy service provision in hospitals has been reported to be linked with improved clinical and economic outcomes in hospitalized patients. Furthermore, critical care pharmacist (CCP) inclusion in patient care rounds, has also been reported to be associated with medication optimization, adverse event prevention (ADEs), cost reduction, and reduced mortality. However few studies have reported on the impact of CCP in critically ill patients with infections. The primary objective of this study is to describe (CCP) interventions related to clinical and cost savings outcomes in this population. Methods: We conducted a retrospective observational study in a 26-bed adult intensive care unit at an academic medical center located in the eastern province of Saudi Arabia. We screened the hospital information system for pharmacist interventions for one year, starting from Jan 2019 to Dec 2019. All clinical pharmacist interventions (CPIs) were reviewed and classified per type and only those related to antibiotic dosing recommendations were included in the study. Intervention type and class were divided into sections based on the recently published evidence-based framework. Results: For a period of 12 months, 430 recommended interventions were analyzed for 147 critically ill patients. Four categories of CCP interventions were identified (i.e. individualization of patient care, resource utilization, adverse event prevention, administrative and supportive tasks. The highest number of interventions were recorded for individualized patient care; which was classified under antimicrobial therapy initiation and streamlining (53%), with an estimated annual cost saving of $89,738; renal dosage adjustments: for both non-continuous renal replacement therapy and dosage adjustment with renal replacement therapy was (15.8%); with an estimated cost saving of $159,679.7. the 2nd highest cost saving was attributed to ADE prevention representing 2% with an estimated saving of $29,495.25, and antimicrobial pharmacokinetic evaluation represented (8.3%) with an estimated saving of $5,508 respectively. Conclusions: Pharmacist involvement in critically ill patients with infections was associated with significant clinical and cost-saving outcomes, mainly in the area of individualization of patient care." @default.
- W4313220652 created "2023-01-06" @default.
- W4313220652 creator A5005133722 @default.
- W4313220652 date "2022-12-15" @default.
- W4313220652 modified "2023-09-30" @default.
- W4313220652 title "973: CLINICAL AND COST-SAVING OUTCOMES ATTRIBUTED TO PHARMACIST ROUNDING IN ICU PATIENTS WITH INFECTION" @default.
- W4313220652 doi "https://doi.org/10.1097/01.ccm.0000909620.07670.78" @default.
- W4313220652 hasPublicationYear "2022" @default.
- W4313220652 type Work @default.
- W4313220652 citedByCount "0" @default.
- W4313220652 crossrefType "journal-article" @default.
- W4313220652 hasAuthorship W4313220652A5005133722 @default.
- W4313220652 hasBestOaLocation W43132206521 @default.
- W4313220652 hasConcept C10446079 @default.
- W4313220652 hasConcept C104863432 @default.
- W4313220652 hasConcept C126322002 @default.
- W4313220652 hasConcept C129930760 @default.
- W4313220652 hasConcept C159110408 @default.
- W4313220652 hasConcept C177713679 @default.
- W4313220652 hasConcept C194828623 @default.
- W4313220652 hasConcept C197934379 @default.
- W4313220652 hasConcept C23131810 @default.
- W4313220652 hasConcept C27415008 @default.
- W4313220652 hasConcept C2776376669 @default.
- W4313220652 hasConcept C2777288759 @default.
- W4313220652 hasConcept C2779457091 @default.
- W4313220652 hasConcept C2908647359 @default.
- W4313220652 hasConcept C512399662 @default.
- W4313220652 hasConcept C71924100 @default.
- W4313220652 hasConcept C99454951 @default.
- W4313220652 hasConceptScore W4313220652C10446079 @default.
- W4313220652 hasConceptScore W4313220652C104863432 @default.
- W4313220652 hasConceptScore W4313220652C126322002 @default.
- W4313220652 hasConceptScore W4313220652C129930760 @default.
- W4313220652 hasConceptScore W4313220652C159110408 @default.
- W4313220652 hasConceptScore W4313220652C177713679 @default.
- W4313220652 hasConceptScore W4313220652C194828623 @default.
- W4313220652 hasConceptScore W4313220652C197934379 @default.
- W4313220652 hasConceptScore W4313220652C23131810 @default.
- W4313220652 hasConceptScore W4313220652C27415008 @default.
- W4313220652 hasConceptScore W4313220652C2776376669 @default.
- W4313220652 hasConceptScore W4313220652C2777288759 @default.
- W4313220652 hasConceptScore W4313220652C2779457091 @default.
- W4313220652 hasConceptScore W4313220652C2908647359 @default.
- W4313220652 hasConceptScore W4313220652C512399662 @default.
- W4313220652 hasConceptScore W4313220652C71924100 @default.
- W4313220652 hasConceptScore W4313220652C99454951 @default.
- W4313220652 hasIssue "1" @default.
- W4313220652 hasLocation W43132206521 @default.
- W4313220652 hasLocation W43132206522 @default.
- W4313220652 hasOpenAccess W4313220652 @default.
- W4313220652 hasPrimaryLocation W43132206521 @default.
- W4313220652 hasRelatedWork W1976052754 @default.
- W4313220652 hasRelatedWork W1993225408 @default.
- W4313220652 hasRelatedWork W2006018047 @default.
- W4313220652 hasRelatedWork W2167619271 @default.
- W4313220652 hasRelatedWork W2409554046 @default.
- W4313220652 hasRelatedWork W3018707521 @default.
- W4313220652 hasRelatedWork W3123223404 @default.
- W4313220652 hasRelatedWork W2107049985 @default.
- W4313220652 hasRelatedWork W2465042241 @default.
- W4313220652 hasRelatedWork W3140911952 @default.
- W4313220652 hasVolume "51" @default.
- W4313220652 isParatext "false" @default.
- W4313220652 isRetracted "false" @default.
- W4313220652 workType "article" @default.